Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, U.K.
The Centre for Diabetes, Endocrinology and Research (CEDAR), Royal Surrey County Hospital, Guildford, Surrey, U.K.
Diabetes Care. 2017 Nov;40(11):1486-1493. doi: 10.2337/dc17-0542. Epub 2017 Aug 31.
This study was conducted to describe the incidence of diabetes following pancreatic disease, assess how these patients are classified by clinicians, and compare clinical characteristics with type 1 and type 2 diabetes.
Primary care records in England ( = 2,360,631) were searched for incident cases of adult-onset diabetes between 1 January 2005 and 31 March 2016. We examined demographics, diabetes classification, glycemic control, and insulin use in those with and without pancreatic disease (subcategorized into acute pancreatitis or chronic pancreatic disease) before diabetes diagnosis. Regression analysis was used to control for baseline potential risk factors for poor glycemic control (HbA ≥7% [53 mmol/mol]) and insulin requirement.
We identified 31,789 new diagnoses of adult-onset diabetes. Diabetes following pancreatic disease (2.59 [95% CI 2.38-2.81] per 100,000 person-years) was more common than type 1 diabetes (1.64 [1.47-1.82]; < 0.001). The 559 cases of diabetes following pancreatic disease were mostly classified by clinicians as type 2 diabetes (87.8%) and uncommonly as diabetes of the exocrine pancreas (2.7%). Diabetes following pancreatic disease was diagnosed at a median age of 59 years and BMI of 29.2 kg/m. Diabetes following pancreatic disease was associated with poor glycemic control (adjusted odds ratio, 1.7 [1.3-2.2]; < 0.001) compared with type 2 diabetes. Insulin use within 5 years was 4.1% (3.8-4.4) with type 2 diabetes, 20.9% (14.6-28.9) with diabetes following acute pancreatitis, and 45.8% (34.2-57.9) with diabetes following chronic pancreatic disease.
Diabetes of the exocrine pancreas is frequently labeled type 2 diabetes but has worse glycemic control and a markedly greater requirement for insulin.
本研究旨在描述胰腺疾病后糖尿病的发病率,评估临床医生对这些患者的分类方式,并比较 1 型和 2 型糖尿病患者的临床特征。
在英格兰,我们对 2005 年 1 月 1 日至 2016 年 3 月 31 日期间新诊断为成人发病型糖尿病的病例进行了初级保健记录搜索。我们观察了糖尿病诊断前有无胰腺疾病(急性胰腺炎或慢性胰腺疾病亚组)患者的人口统计学特征、糖尿病分类、血糖控制和胰岛素使用情况。我们使用回归分析控制了血糖控制不良(HbA1c≥7%[53mmol/mol])和胰岛素需求的潜在基线风险因素。
我们共确定了 31789 例新诊断的成人发病型糖尿病。胰腺疾病后发生的糖尿病(每 100000 人年 2.59[95%CI2.38-2.81])比 1 型糖尿病(每 100000 人年 1.64[1.47-1.82])更为常见(<0.001)。559 例胰腺疾病后发生的糖尿病,临床医生大多将其分类为 2 型糖尿病(87.8%),很少归类为外分泌胰腺糖尿病(2.7%)。胰腺疾病后发生的糖尿病中位诊断年龄为 59 岁,BMI 为 29.2kg/m2。与 2 型糖尿病相比,胰腺疾病后发生的糖尿病患者血糖控制不佳的风险更高(调整比值比,1.7[1.3-2.2];<0.001)。在 5 年内,使用胰岛素的患者中,2 型糖尿病患者占 4.1%(3.8%-4.4%),急性胰腺炎后糖尿病患者占 20.9%(14.6%-28.9%),慢性胰腺疾病后糖尿病患者占 45.8%(34.2%-57.9%)。
外分泌胰腺糖尿病常被归类为 2 型糖尿病,但血糖控制更差,对胰岛素的需求明显更大。